• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Up 1.57% Nasdaq Up 2.12%

    More On GLAXO.NS

    Quotes

    Charts

    News & Info

    Company

    Analyst Coverage

    Ownership

    • Major Holders
    • Insider Transactions
    • Insider Roster

    Financials

    GlaxoSmithkline Pharmaceuticals Limited (GLAXO.NS)

    -NSE
    3,500.50 Down 3.35(0.10%) 12:13AM EDT
    Prev Close:3,503.85
    Open:3,510.00
    Bid:3,498.00
    Ask:3,503.00
    1y Target Est:N/A
    Beta:N/A
    Next Earnings Date:N/A
    Day's Range:3,500.50 - 3,510.00
    52wk Range:3,032.05 - 3,872.00
    Volume:222
    Avg Vol (3m):5,850
    Market Cap:296.42B
    P/E (ttm):78.66
    EPS (ttm):44.50
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in INR.

    Headlines

    • No Headlines available for GLAXO.NS at this time.

    Key Statistics

    Forward P/E (1 yr):48.00
    P/S (ttm):10.72
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Mar-17) :65.36
    Quarterly EPS Est (Jun-16) :11.00
    Mean Recommendation*:3.5
    PEG Ratio (5 yr expected):3.56

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    GlaxoSmithKline Pharmaceuticals Limited operates as research-based healthcare and pharmaceutical company worldwide. It manufactures, distributes, and trades pharmaceuticals for a range of therapeutic areas, including analgesic, anti-infective, ant... View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback